Cassava Sciences Files Routine 8-K, Confirms NASDAQ Listing
Ticker: FLNA · Form: 8-K · Filed: Feb 7, 2024 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | 8-K |
| Filed Date | Feb 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, corporate-governance
TL;DR
**Cassava Sciences filed a routine 8-K, confirming its NASDAQ listing; no new news here.**
AI Summary
Cassava Sciences, Inc. filed an 8-K on February 7, 2024, to update its registration information, specifically noting its Common Stock, $0.001 par value, is registered on the NASDAQ Capital Market under the trading symbol SAVA. This filing is a routine update, indicating no major operational or financial changes. For investors, this means the company is maintaining its compliance with SEC regulations, which is a positive sign of good governance, but it doesn't signal any new developments that would directly impact the stock price.
Why It Matters
This filing is a standard compliance update, confirming Cassava Sciences' stock is listed on the NASDAQ Capital Market. It reassures investors about the company's regulatory adherence but doesn't introduce new financial or operational news.
Risk Assessment
Risk Level: low — This 8-K filing is a routine administrative update and does not present any new financial or operational risks to the company.
Analyst Insight
A smart investor would recognize this as a routine compliance filing with no new material information to impact investment decisions. It's a 'no news is good news' scenario, confirming ongoing regulatory adherence.
Key Numbers
- $0.001 — par value per share (the stated par value of Cassava Sciences' Common Stock)
Key Players & Entities
- Cassava Sciences, Inc. (company) — the registrant filing the 8-K
- NASDAQ Capital Market (company) — the exchange where Cassava Sciences' Common Stock is registered
- $0.001 (dollar_amount) — par value of the Common Stock
- February 7, 2024 (date) — date of the earliest event reported in the 8-K
FAQ
What is the purpose of this 8-K filing by Cassava Sciences, Inc.?
The 8-K filing by Cassava Sciences, Inc. on February 7, 2024, is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily to report 'Other Events' and 'Financial Statements and Exhibits'. It specifically confirms that its Common Stock, $0.001 par value, is registered on the NASDAQ Capital Market under the trading symbol SAVA.
What is the trading symbol and exchange for Cassava Sciences' common stock?
Cassava Sciences' Common Stock trades under the symbol SAVA and is registered on the NASDAQ Capital Market, as stated in the filing.
What is the par value of Cassava Sciences' Common Stock?
The par value of Cassava Sciences' Common Stock is $0.001, as indicated in the 'Securities registered pursuant to Section 12(b) of the Act' section of the filing.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is February 7, 2024.
What is Cassava Sciences, Inc.'s business address?
Cassava Sciences, Inc.'s business address is 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas 78731, with a business phone number of (512) 501-2444.
Filing Stats: 414 words · 2 min read · ~1 pages · Grade level 10 · Accepted 2024-02-07 09:20:27
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value SAVA NASDAQ Capital Market
Filing Documents
- f8k_020724.htm (8-K) — 14KB
- exh_991.htm (EX-99.1) — 16KB
- 0001171843-24-000648.txt ( ) — 230KB
- gnw-20190101.xsd (EX-101.SCH) — 3KB
- gnw-20190101_def.xml (EX-101.DEF) — 25KB
- gnw-20190101_lab.xml (EX-101.LAB) — 33KB
- gnw-20190101_pre.xml (EX-101.PRE) — 22KB
- f8k_020724_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On February 7, 2024, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release dated February 7, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cassava Sciences, Inc. Date: February 7, 2024 By: /s/ Eric J. Schoen Eric J. Schoen Chief Financial Officer